Drug delivery device

Patent metadata

Field	Value
Publication number	US-10300210-B2
Application number	US-201715414679-A
Country	US
Kind code	B2
Filing date	Jan 25, 2017
Priority date	Jul 15, 2011
Publication date	May 28, 2019
Grant date	May 28, 2019

Abstract

A drug delivery device comprising;
a housing; a cylindrical member configured to be rotatably supported inside the housing, wherein the outer surface of the cylindrical member is provided with at least first and second tracks together forming an encoder, each track comprising conductive segments and non-conductive segments; and at least first and second groups of contacts configured to engage the first and second tracks respectively at predetermined intervals along the length of the track.

First claim

The invention claimed is:

1. A drug delivery device comprising:
a housing;
a cylindrical member configured to be rotatably supported inside the housing, wherein an outer surface of the cylindrical member is provided with a first track and a second track, the first track and the second track together forming an encoder, each of the first track and the second track comprising conductive segments and non-conductive segments;
at least first and second groups of contacts configured to engage the first track and the second track, respectively, at predetermined intervals along a length of the first track and the second track wherein the first track and the second track are separated by a non-conductive strip;
a switch configured to:
in a first position, connect electrically the first track and the second track; and
in a second position, isolate electrically the first track and the second track; and
a user actuatable plunger configured to cause expulsion of a drug from the drug delivery device, wherein depression of the plunger causes the switch to switch from the first position to the second position.

2. The drug delivery device of claim 1 , wherein the first track and the second track are helical tracks and wherein the housing and the cylindrical member are configured such that the cylindrical member moves in a first axial direction relative to the housing when rotated in a first rotational direction relative to the housing.

3. The drug delivery device of claim 1 , wherein the cylindrical member is configured to be rotatable from an initial position into a number of discrete rotational positions and wherein the contacts of the first group of contacts are arranged such that a sequence of conductive and non-conductive segments engaged by the contacts of the first group of contacts in successive discrete rotational positions forms a Gray code.

4. The drug delivery device of claim 1 , wherein the encoder has a higher bit depth than each individual track.

5. The drug delivery device of claim 1 , wherein a coding depth of the first track and a coding depth of the second track are combined such that a combined coding depth of the encoder equals a sum of the coding depths of the first track and the second track.

6. The drug delivery device of claim 1 , wherein each of the first track and the second track comprises a single track bit code.

7. The drug delivery device of claim 1 , wherein the first group of contacts comprises more contacts than the second group of contacts.

8. The drug delivery device of claim 7 , wherein the first group of contacts comprises five contacts and the second group of contacts comprises two contacts.

9. The drug delivery device of claim 1 , wherein the contacts of the first group of contacts are spaced such as to engage every sixth segment of the first track and wherein the contacts of the second group of contacts are spaced such as to engage every twenty-seventh segment of the second track.

10. The drug delivery device of claim 1 , wherein the conductive segments within each of the first track and the second track are electrically connected to all of the other conductive segments in that track.

11. The drug delivery device of claim 10 , wherein the conductive segments within each of the first track and the second track are electrically connected together by first and second common ground tracks immediately adjacent to respective ones of the first track and the second track.

12. The drug delivery device of claim 1 , wherein the conductive and non-conductive segments of the first track and the second track are arranged such that, when the cylindrical member is in an initial position, each contact is configured to engage a conductive segment.

13. The drug delivery device of claim 1 , wherein the device further comprises:
a display; and
a processor configured to receive and interpret electrical signals from the contacts, to control application of electrical signals to the contacts and to control an operation of the display.

14. The drug delivery device of claim 13 , wherein the processor is configured to cause an electrical signal to be applied to at least a first contact of the second group of contacts and simultaneously to monitor signals at at least one other contact in order to determine a position of the cylindrical member.

15. The drug delivery device of claim 13 , wherein the processor is configured:
to cause an electrical signal to be applied to a first contact of the second group of contacts and simultaneously to monitor electrical signals at the first group of contacts; and
when no signals are detected at any of the first group of contacts, to cause an electrical signal to be applied to a second contact of the second group of contacts and simultaneously to monitor electrical signals at the first group of contacts.

16. The drug delivery device of claim 15 , wherein the processor is configured, in response to detecting no signals at any of the first group of contacts when an electrical signal is applied to the second contact of the second group of contacts, to cause an electrical signal to be applied to a first contact of the first group of contacts and simultaneously to monitor electrical signals at other contacts of the first group of contacts.

Assignees

• Sanofi Aventis Deutschland

Inventors

• Butler Joseph
• Moore David
• Draper Paul Richard
• Gilmore Stephen Francis
• Morris Anthony Paul

Classifications

• A61M5/31551 Primary

  including axial movement of dose setting member · CPC title

• A61M2005/2488

  via rotation, e.g. threads or bayonet · CPC title

• A61M5/31593

  Multi-dose, i.e. individually set dose repeatedly administered from the same medicament reservoir · CPC title

• A61M5/31541

  Means preventing setting of a dose beyond the amount remaining in the cartridge · CPC title

• A61M2005/3126

  Specific display means related to dosing · CPC title